Sort
46,585 grants matching “heart failure”
Mosaic loss of Y chromosome in blood and heart failure
$403,750Kenneth Walsh · University Of Virginia · R01 · FY2023 · AG
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction
$403,750Brent A French · University Of Virginia · R01 · FY2022 · HL
Role of Foxa2 in ligand-dependent activation of nuclear receptors
$403,750Irina Bochkis · University Of Virginia · R01 · FY2020 · DK
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity
$403,750Kenneth Walsh · University Of Virginia · R01 · FY2024 · HL
DYRK1a as a therapeutic target to treat myocardial infarction
$403,750Matthew J Wolf · University Of Virginia · R01 · FY2024 · HL
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
$403,750Francisco Altamirano · Methodist Hospital Research Institute · R01 · FY2022 · HL
Genetic Metabolic Myopathy - Acid Maltase Deficiency
$403,740Vittorio Sartorelli · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR
Landscapes for Cell State Transition Leveraging by Single-Cell Multi-Omics
$403,739Guangyu Wang · Methodist Hospital Research Institute · R35 · FY2025 · GM
Landscapes for Cell State Transition Leveraging by Single-Cell Multi-Omics
$403,739Guangyu Wang · Methodist Hospital Research Institute · R35 · FY2024 · GM
Landscapes for Cell State Transition Leveraging by Single-Cell Multi-Omics
$403,739Guangyu Wang · Methodist Hospital Research Institute · R35 · FY2023 · GM
TARGETING INSULIN RESISTANCE TO IMPROVE ABNORMAL CARDIOVASCULAR CONTROL IN DIABETES
$403,732Masaki Mizuno · Ut Southwestern Medical Center · R01 · FY2020 · HL
Cardiovascular and Cerebrovascular Risk Factors for Mobility Limitation in the Jackson Heart Study
$403,717Michelle Christina Odden · Stanford University · R01 · FY2020 · AG
Carotid Intima-Media Thickness in Chronic Kidney Disease: a CRIC ancillary study
$403,652Sylvia E Rosas · University Of Pennsylvania · R01 · FY2011 · DK
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future
$403,590Jennifer M. Yeh · Boston Children'S Hospital · R01 · FY2020 · CA
Project 3: Molecular Mechanisms of Myofilament Dysfunction in Heart Failure
$403,587Pieter P. De Tombe · University Of Illinois At Chicago · P01 · FY2018 · HL
Molecular Physiology of Myocardial Troponin I Variants
$403,578Johns Hopkins University · R01 · FY2004 · HL
Study of Osteoporotic Fractures
$403,572Kristine Ensrud · University Of Minnesota · R01 · FY2015 · AG
Homing and Genetic Modification of Mesenchymal Stem Cell
$403,558Brigham And Women'S Hospital · R01 · FY2003 · HL
BMP10 IN CARDIOVASCULAR DEVELOPMENT AND HEREDITARY HEMORRHAGIC TELANGIECTASIA
$403,548Beth L Roman · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL
Effects of glycemic control on immunity
$403,534Thomas P. Shanley · University Of Michigan At Ann Arbor · R01 · FY2009 · HL
Analysis of a Novel Homeobox gene in CV Development
$403,521Jonathan A Epstein · University Of Pennsylvania · R01 · FY2016 · HL
Elafin to reverse pulmonary arterial hypertension
$403,512Marlene Rabinovitch · Stanford University · P01 · FY2012 · HL
Elafin to reverse pulmonary arterial hypertension
$403,512Marlene Rabinovitch · Stanford University · P01 · FY2011 · HL
Developing Oral LT3 Therapy for Heart Failure
$403,463Anne R Cappola · University Of Pennsylvania · R61 · FY2019 · HL
Clinical Core
$403,453Marc A Simon · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · HL